SINGAPORE'S Agency for Science, Technology and Research's (A*Star) newly-rebranded commercial arm, A*ccelerate and private equity (PE)-backed Hafnium Hafaway will pump up to S$20 million to bring to market innovations in the specialty chemical sub-sector. Read more at The Business Times.
Singapore Latest News, Singapore Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
A*Star's commercial arm, investors raise co-investment capital to over S$85mSINGAPORE'S Agency for Science, Technology and Research’s (A*Star) newly-rebranded commercial arm, A*ccelerate, will be entering into new agreements with investors such as Startup-O, Hafnium Hafaway, Marvelstone, Trendlines and Dymon Asia Ventures. Read more at The Business Times.
Read more »
With eye on local debt, China vows to bolster watch over 'specialty towns'Top Chinese ministries have been told to improve the quality of the hundreds of so-called 'specialty towns' that have sprung up in the past two ...
Read more »
Mallinckrodt plans to spin off specialty generics businessREUTERS: Drugmaker Mallinckrodt Plc said on Thursday it planned to spin off its specialty generics business to shareholders by the second half of ...
Read more »